Answers are grounded in this paper and cite their sources.
Study verifies TRPV1 expression in canine keratinocytes, suggesting roles in skin conditions.
The interest for the endovanilloid system and for transient receptor potential vanilloid 1 ( TRPV 1) is continuously increasing, due to their involvement in inflammation, nociception and pruritus. Even if TRPV 1 enrolment was highlighted in both physiological and pathological conditions, some aspects remain unclear, mostly in veterinary medicine. This study aimed to verify the expression and functionality of TRPV 1 in canine keratinocytes to investigate in vitro the role of TRPV 1 in these cells that are involved in different cutaneous pathologies. Keratinocytes primary cultures were isolated from bioptical samples and cultivated. Binding assay (using 3 [H]‐resiniferatoxin), displacement assay (in the presence of 1.2 nM 3 [H]‐resiniferatoxin) and functional assays (in the presence of 1 μCi/ 45 Ca 2+ ) with vanilloid agonists and antagonists, specifically addressed to TRPV 1 receptor, were performed. Binding assay demonstrated the presence of measurable concentrations of TRPV 1 ( B max = 1,240 ± 120 fmol/mg protein; K d = 0.01 ± 0.004 nM ). Displacement assay highlighted the highest affinity for resiniferatoxin ( RTX ) and 5‐iodo‐resiniferatoxin (5‐I‐ RTX ), among agonists and antagonists, respectively. The same compounds results as the most potent in the functional assays. This study demonstrated the identification and the characterization of TRPV 1 receptor in primary canine keratinocytes cultures. The results are promising for a clinical use, but further in vivo investigations are required.
No takes yet. Share an insight, caveat, or question.
Barbero et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: